Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Aug 2016 for Sagent Pharmaceuticals, Inc., €96k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Jeffrey W. Greve: trading record in brief
Jeffrey W. Greve is a declared insider of Sagent Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 22 February 2016 to 29 August 2016, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 31 August 2016, reports a transaction of €96k in Sagent Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey W. Greve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,962 shares@ US$21.75100.0% of flowCommon StockSEC:0000899243-16-028295:0
4,962 shares0Common StockSEC:0001562180-16-001777:0
2 of 2 declarations
